NCT03998774

Brief Summary

The EquiMolar Oxygen and Nitrous Oxyde mix (EMONO) is listed by the ANSM (National Agency for the Safety of Medicines and Health Products) as drugs with enhanced surveillance. EMONO is a gas composed equally of oxygen and nitrous oxide, presented in bottle. The University Hospital of Nantes is currently conducting a general evaluation of the EMONO use in the hospital context. The department of odontology is part of this movement and wants to study the anxiolytic effect expected during dental care under MEOPA in children in the Dental Care Center. This analysis follows a previous study (MEOPAeDent) that subjectively took into account this anxiolysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2019

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 26, 2019

Completed
Last Updated

September 13, 2021

Status Verified

September 1, 2021

Enrollment Period

11 months

First QC Date

May 28, 2019

Last Update Submit

September 10, 2021

Conditions

Keywords

Nitrous oxideConscious sedationPaediatric dentistry

Outcome Measures

Primary Outcomes (1)

  • Evaluate the anxiolytic effect of EMONO in children during dental care

    The primary endpoint will be a significant variation of heart rate at 3 key moments of the treatment session: * Chair installation * 5 minutes after induction of MEOPA induction * The injection of the local anesthetic

    15 minutes

Secondary Outcomes (2)

  • Assess whether the child's stress is less intense after certain types of dental care under EMONO by the measure of heart rate variation.

    1 minute

  • Assess whether the child's stress is less intense after certain types of dental care under EMONO by the measure Veerkamp Modified VENHAM Anxiety Assessment Scale.

    1 minute

Interventions

Primary Purpose: The main objective of this study is to evaluate the anxiolytic effect of EMONO in children during dental care. Enrollment: 30

Eligibility Criteria

Age3 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children from 3 to 15 years old, requiring MEOPA treatment with local anaesthesia for the first time

You may qualify if:

  • Children from 3 to 15 years,
  • Requiring dental treatment under EMONO including local anesthesia
  • Not opposed, as well as parents, to participate in the study
  • Having a sufficiently cooperative attitude to allow the installation of the monitoring equipment
  • The use of EMONO for dental care must be a first time for the child

You may not qualify if:

  • The excluded patients will be those whose number of care is too important, justifying a general anesthesia. Similarly, patients who do not require anesthesia for their care will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu de Nantes

Nantes, 44000, France

Location

MeSH Terms

Interventions

Meopa

Study Officials

  • Tony Prud'homme

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2019

First Posted

June 26, 2019

Study Start

March 16, 2018

Primary Completion

January 30, 2019

Study Completion

January 30, 2019

Last Updated

September 13, 2021

Record last verified: 2021-09

Locations